{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:49:51Z","timestamp":1777700991009,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,12]]},"DOI":"10.7759\/cureus.105106","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:16:42Z","timestamp":1773328602000},"source":"Crossref","is-referenced-by-count":1,"title":["One Hundred Cerebral Microhemorrhages: Rethinking Cerebral Amyloid Angiopathy in the Era of Amyloid-Targeted Antibodies"],"prefix":"10.7759","author":[{"given":"Amber N","family":"Navarra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey R","family":"Petrella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy J","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman S","family":"Ikramuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Murali","family":"Doraiswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12366","article-title":"Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis","volume":"18","author":"J\u00e4kel L","year":"2022","unstructured":"J\u00e4kel L, De Kort AM, Klijn CJ, Schreuder FH, Verbeek MM. Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis. Alzheimers Dement. 2022, 18:10-28. 10.1002\/alz.12366","journal-title":"Alzheimers Dement"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22516","article-title":"Cerebral amyloid angiopathy in the elderly","volume":"70","author":"Viswanathan A","year":"2011","unstructured":"Viswanathan A, Greenberg SM. Cerebral amyloid angiopathy in the elderly. Ann Neurol. 2011, 70:871-80. 10.1002\/ana.22516","journal-title":"Ann Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-235949","article-title":"Cerebral amyloid angiopathy: an underdiagnosed cause of recurrent neurological symptoms","volume":"14","author":"Shah F","year":"2021","unstructured":"Shah F, Yazdani S, I'anson M, Nazir T. Cerebral amyloid angiopathy: an underdiagnosed cause of recurrent neurological symptoms. BMJ Case Rep. 2021, 14:e235949. 10.1136\/bcr-2020-235949","journal-title":"BMJ Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213716","article-title":"The Boston Criteria v2.0 for cerebral amyloid angiopathy. A SCUBA dive exploration","volume":"104","author":"Charidimou A","year":"2025","unstructured":"Charidimou A. The Boston Criteria v2.0 for cerebral amyloid angiopathy. A SCUBA dive exploration. Neurology. 2025, 104:e213716. 10.1212\/WNL.0000000000213716","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine ZS","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, et al.. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005, 53:695-9. 10.1111\/j.1532-5415.2005.53221.x","journal-title":"J Am Geriatr Soc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A8946","article-title":"Artificial intelligence-assisted detection of amyloid-related imaging abnormalities: promise and pitfalls","volume":"47","author":"Petrella JR","year":"2026","unstructured":"Petrella JR, Liu AJ, Wang LA, Doraiswamy PM. Artificial intelligence-assisted detection of amyloid-related imaging abnormalities: promise and pitfalls. AJNR Am J Neuroradiol. 2026, 47:289-92. 10.3174\/ajnr.A8946","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: appropriate use recommendations","volume":"10","author":"Cummings J","year":"2023","unstructured":"Cummings J, Apostolova L, Rabinovici GD, et al.. Lecanemab: appropriate use recommendations. J Prev Alzheimers Dis. 2023, 10:362-77. 10.14283\/jpad.2023.30","journal-title":"J Prev Alzheimers Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00780.2016","article-title":"Cerebral microhemorrhages: mechanisms, consequences, and prevention","volume":"312","author":"Ungvari Z","year":"2017","unstructured":"Ungvari Z, Tarantini S, Kirkpatrick AC, Csiszar A, Prodan CI. Cerebral microhemorrhages: mechanisms, consequences, and prevention. Am J Physiol Heart Circ Physiol. 2017, 312:H1128-43. 10.1152\/ajpheart.00780.2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-025-02250-5","article-title":"Clinical efficacy, safety and imaging effects of oral valiltramiprosate in APOE\u03b54\/\u03b54 homozygotes with early Alzheimer\u2019s disease: results of the phase III, randomized, double-blind, placebo-controlled, 78-week APOLLOE4 trial","volume":"85","author":"Abushakra S","year":"2025","unstructured":"Abushakra S, Power A, Watson D, et al.. Clinical efficacy, safety and imaging effects of oral valiltramiprosate in APOE\u03b54\/\u03b54 homozygotes with early Alzheimer\u2019s disease: results of the phase III, randomized, double-blind, placebo-controlled, 78-week APOLLOE4 trial. Drugs. 2025, 85:1455-72. 10.1007\/s40265-025-02250-5","journal-title":"Drugs"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-191257","article-title":"Association of cerebral microbleeds with cognitive decline: a longitudinal study","volume":"75","author":"Li L","year":"2020","unstructured":"Li L, Wu DH, Li HQ, et al.. Association of cerebral microbleeds with cognitive decline: a longitudinal study. J Alzheimers Dis. 2020, 75:571-9. 10.3233\/JAD-191257","journal-title":"J Alzheimers Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01161-5","article-title":"The effects of imaging markers on clinical trajectory in cerebral amyloid angiopathy: a longitudinal study in a memory clinic","volume":"15","author":"Jang H","year":"2023","unstructured":"Jang H, Chun MY, Kim HJ, Na DL, Seo SW. The effects of imaging markers on clinical trajectory in cerebral amyloid angiopathy: a longitudinal study in a memory clinic. Alzheimers Res Ther. 2023, 15:14. 10.1186\/s13195-023-01161-5","journal-title":"Alzheimers Res Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/str.57.suppl_1.TP264","article-title":"Abstract TP264: comparative performance of 7T and conventional MRI for CAA markers","volume":"57","author":"Ahmadi R","year":"2026","unstructured":"Ahmadi R, Ozutemiz C, Kumar K, Valcinord CL, Tessmer M, Staugaitis A, Streib C. Abstract TP264: comparative performance of 7T and conventional MRI for CAA markers. Stroke. 2026, 57:TP264. 10.1161\/str.57.suppl_1.TP264","journal-title":"Stroke"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083869","article-title":"Current management and therapeutic strategies for cerebral amyloid angiopathy","volume":"22","author":"Inoue Y","year":"2021","unstructured":"Inoue Y, Ando Y, Misumi Y, Ueda M. Current management and therapeutic strategies for cerebral amyloid angiopathy. Int J Mol Sci. 2021, 22:3869. 10.3390\/ijms22083869","journal-title":"Int J Mol Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd7522","article-title":"APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function","volume":"13","author":"Xiong M","year":"2021","unstructured":"Xiong M, Jiang H, Serrano JR, et al.. APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function. Sci Transl Med. 2021, 13:10.1126\/scitranslmed.abd7522","journal-title":"Sci Transl Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70594","article-title":"Prevalence and risk factors of cerebral microhemorrhages and superficial siderosis in cognitively unimpaired older adults: analysis from the CHARIOT-PRO SubStudy","volume":"21","author":"Kang S","year":"2025","unstructured":"Kang S, Kafetsouli D, Ford J, et al.. Prevalence and risk factors of cerebral microhemorrhages and superficial siderosis in cognitively unimpaired older adults: analysis from the CHARIOT-PRO SubStudy. Alzheimers Dement. 2025, 21:e70594. 10.1002\/alz.70594","journal-title":"Alzheimers Dement"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318221ad36","article-title":"Cerebral microhemorrhage and brain \u03b2-amyloid in aging and Alzheimer disease","volume":"77","author":"Yates PA","year":"2011","unstructured":"Yates PA, Sirisriro R, Villemagne VL, Farquharson S, Masters CL, Rowe CC. Cerebral microhemorrhage and brain \u03b2-amyloid in aging and Alzheimer disease. Neurology. 2011, 77:48-54. 10.1212\/WNL.0b013e318221ad36","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/472971-one-hundred-cerebral-microhemorrhages-rethinking-cerebral-amyloid-angiopathy-in-the-era-of-amyloid-targeted-antibodies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:16:43Z","timestamp":1773328603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/472971-one-hundred-cerebral-microhemorrhages-rethinking-cerebral-amyloid-angiopathy-in-the-era-of-amyloid-targeted-antibodies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.105106","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,12]]}}}